Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...

a timely and accurate diagnosis can improve patients’ chances to benefit from current treatments and participate in clinical trials. We believe accelerating the diagnosis of Alzheimer’s can ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

This step is important to make sure that only the best and safest treatments are tested on humans in clinical trials. The team examined postmortem brain tissues from Alzheimer's patients using ...

Cambridge, Massachusetts Monday, January 13, 2025, 15:00 Hrs [IST] ...

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

(“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease ...

Improve doctors’ ability to tailor treatment doses to an individual’s needs. Provide new ways to measure the effects of drugs used to treat dementia. Sleep disturbances are common in dementia and can ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment ... based on current information and ...